Category: Latest News
-

Broadcom Advances as Alphabet’s $80 Billion AI Capital Raise Highlights Infrastructure Demand (AVGO)
Broadcom (NASDAQ:AVGO) shares climbed more than 6% in premarket trading on Tuesday after Alphabet announced plans to raise $80 billion in new equity capital to support a major expansion of its artificial intelligence infrastructure. The fundraising initiative reinforced investor confidence in companies positioned to benefit from the rapid growth of AI-related spending, including Broadcom, which…
-

Oracle Shares Retreat as Investors Assess AI Spending Implications After Alphabet Fundraising Plan (ORCL)
Oracle (NYSE:ORCL) shares moved lower in premarket trading on Tuesday as investors evaluated the broader implications of escalating artificial intelligence infrastructure costs following Alphabet’s announcement of a major capital-raising initiative. The stock fell 4.2% before the opening bell, giving back part of the gains recorded during the previous session. Alphabet’s Funding Plan Raises Questions About…
-

Alphabet Launches $80 Billion Capital Raise to Fund AI Expansion with Berkshire Hathaway Support (GOOG)
Alphabet Inc. (NASDAQ:GOOG) has announced plans to raise $80 billion in new equity capital as the company ramps up investment in artificial intelligence infrastructure to meet rapidly growing demand for its AI products and services. The financing initiative includes support from Warren Buffett’s Berkshire Hathaway Inc., which has committed $10 billion through a private placement,…
-

Intel Expands AI Portfolio with New Infrastructure Solutions and Xeon 6+ Launch at Computex (INTC)
Intel Corporation (NASDAQ:INTC) introduced a range of new artificial intelligence infrastructure technologies and processor offerings at Computex 2026 in Taipei, showcasing its latest efforts to strengthen its position across AI, cloud computing and data center markets. The announcements included new rackscale AI systems, the commercial availability of Xeon 6+ processors and a series of strategic…
-

Tencent Shares Jump as Company Advances AI Agent Development (TME)
Tencent (NYSE:TME) shares climbed 10.5% on Tuesday after reports emerged that the company is testing a prototype version of its embedded artificial intelligence agent, fueling investor optimism about its position in the rapidly evolving AI market. The move reflects growing confidence that Tencent could become a more prominent player in artificial intelligence as it expands…
-

Donaldson Shares Rise After Third-Quarter Results Top Expectations (DCI)
Donaldson Company (NYSE:DCI) traded higher in premarket activity on Tuesday after reporting third-quarter results that exceeded analyst forecasts on both earnings and revenue, supported by strong performances in its Mobile Solutions and Life Sciences businesses. Shares of the filtration technology manufacturer gained nearly 4% following the release. Revenue and Earnings Come in Ahead of Forecasts…
-

Goldman Sachs Downgrades Intuit as AI Tax Rivals Intensify Competitive Pressure (INTU)
Intuit (NASDAQ:INTU) came under pressure on Tuesday after Goldman Sachs downgraded the stock to Sell from Neutral and sharply reduced its 12-month price target to $276 from $519, citing mounting competitive risks in the tax software market that could weigh on the company’s long-term growth outlook. The brokerage said increasing competition from emerging AI-driven tax…
-

STMicro Raises Data Centre Revenue Forecast to $1 Billion as AI Demand Accelerates (STM)
STMicroelectronics (NYSE:STM) increased its revenue expectations for its data centre business on Tuesday, citing strong momentum from artificial intelligence infrastructure investment and ongoing expansion of manufacturing capacity. The Franco-Italian semiconductor manufacturer, which counts Tesla and Apple among its customers, now expects its data centre operations to generate approximately $1 billion in revenue during 2026. The…
-

Abivax Shares Tumble Despite Strong Ulcerative Colitis Trial Results as Safety Concerns Emerge (ABVX)
Abivax (NASDAQ:ABVX) shares fell sharply on Tuesday after investors focused on reports of rare malignancy cases in a late-stage clinical trial, overshadowing better-than-expected efficacy results for the company’s experimental ulcerative colitis treatment. The Paris-listed biotech company saw its stock drop more than 32% in early European trading by 07:34 GMT. Obefazimod Delivers Strong Remission Rates…
-

Stellantis Commits Over €1 Billion to Mulhouse Plant for New Peugeot Vehicle Programme (STLA)
Stellantis (NYSE:STLA) has announced plans to invest more than €1 billion in France to support production of three new Peugeot models at its Mulhouse manufacturing facility. The vehicles, which will be offered in both electric and hybrid versions, are expected to enter production in 2029. New C-Segment Models to Strengthen Peugeot’s Market Position According to…